Viridian Therapeutics, Inc.\DE Balance Sheet (2014-2026) | VRDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	27.70M	138.88M	42.30M	30.86M	31.29M	344.21M	155.58M	88.52M	87.08M	111.60M	102.83M	91.64M	107.67M	200.32M	99.59M	116.22M	117.32M	169.65M	212.38M	176.35M
Receivables - Net (Quarter)		1.00M
Receivables - Other (Quarter)		0.48M	0.45M	0.52M	0.69M	0.40M	0.10M	0.13M	0.10M	0.10M	0.10M	0.10M		0.01M				70.00M
Receivables (Quarter)		1.48M
Inventory (Quarter)
Prepaid Assets (Quarter)	4.11M	3.65M	2.75M	3.44M	4.25M	5.63M	6.52M	8.62M	11.94M	10.73M	9.01M	13.53M	10.30M	14.10M	20.88M	20.61M	15.39M	11.01M	19.58M	22.56M
Current Assets (Quarter)	115.46M	217.94M	200.16M	179.39M	166.15M	437.36M	431.17M	382.60M	346.33M	323.84M	486.48M	626.82M	581.66M	767.36M	738.46M	657.24M	578.75M	571.91M	894.23M	784.74M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.30M	0.35M	0.38M	0.69M	0.75M	0.82M	1.33M	1.59M	1.88M	1.80M	1.67M	1.53M	1.51M	1.29M	1.24M	1.16M	1.09M	1.12M	1.23M	1.13M
Other Non-Current Assets (Quarter)	0.10M	1.46M	1.49M	1.54M	1.51M	1.15M	0.98M	0.98M	1.18M	1.26M	0.60M	0.56M	0.66M	0.85M	0.50M	0.49M	0.51M	1.52M	1.54M	0.89M
Non-Current Assets (Quarter)	2.74M	3.27M	3.55M	3.78M	3.66M	3.23M	3.92M	4.04M	5.14M	4.92M	3.95M	3.56M	4.00M	4.54M	3.94M	3.74M	3.57M	5.22M	5.18M	4.27M
Assets (Quarter)	118.20M	221.21M	203.71M	183.16M	169.81M	440.58M	435.09M	386.64M	351.47M	328.76M	490.42M	630.38M	585.66M	771.90M	742.40M	660.98M	582.32M	577.14M	899.42M	789.02M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.39M	3.73M	2.33M	2.54M	4.06M	12.15M	14.23M	7.87M	4.13M	3.73M	2.24M	2.68M	3.14M	6.34M	2.14M	3.89M	8.52M	10.06M	8.68M	13.31M
Notes Payables (Quarter)
Payables (Quarter)	2.39M	3.73M	2.33M	2.54M	4.06M	12.15M	14.23M	7.87M	4.13M	3.73M	2.24M	2.68M	3.14M	6.34M	2.14M	3.89M	8.52M	10.06M	8.68M	13.31M
Accumulated Expenses (Quarter)	14.15M	10.32M	11.02M	11.56M	17.04M	12.77M	18.83M	21.43M	24.24M	19.22M	24.11M	23.16M	30.37M	34.74M	45.73M	29.55M	35.34M	40.63M	62.01M	38.49M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)													2.96M				8.44M
Current Leases (Quarter)
Current Deferred Revenue (Quarter)	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M	0.29M
Total Current Liabilities (Quarter)	16.83M	14.34M	13.64M	14.39M	21.39M	25.21M	33.35M	29.59M	28.66M	23.25M	26.64M	26.13M	36.76M	41.36M	47.87M	33.73M	52.59M	50.70M	70.70M	51.80M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)											20.20M		17.49M	20.52M		20.68M	12.35M	20.89M	34.24M	36.09M
Non-Current Deffered Revenue (Quarter)			1.15M	1.08M	1.00M	0.93M	0.86M	0.79M	0.72M	0.65M	0.57M	0.50M	0.43M	0.36M	0.28M	0.21M	0.14M
Preferred Stock Liabilities (Quarter)
Other Non-Current Liabilities (Quarter)	1.17M	2.27M	1.21M	1.06M	0.94M	0.81M	1.17M	1.04M	1.53M	1.29M	0.99M	0.90M	1.65M	2.16M		1.88M	2.08M	2.58M	20.03M	12.50M
Total Non-Current Liabilities (Quarter)	18.12M	14.34M	14.79M	15.46M	26.98M	30.76M	38.85M	35.05M	34.08M	43.89M	47.41M	46.95M	54.68M	62.24M	70.76M	54.62M	65.08M	71.59M	157.22M	140.51M
Total Liabilities (Quarter)	19.29M	16.61M	15.99M	16.52M	27.92M	31.57M	40.03M	36.09M	35.61M	45.18M	48.40M	47.85M	56.33M	64.40M	70.76M	56.51M	67.16M	74.17M	177.25M	153.01M
Shareholder's Equity
Total Debt (Quarter)											20.20M		20.45M	20.52M		20.68M	20.79M	20.89M	34.24M	36.09M
Common Equity (Quarter)	98.91M	204.59M	187.72M	166.64M	141.90M	409.01M	395.06M	350.55M	315.86M	283.58M	442.02M	582.53M	529.34M	707.50M	671.64M	604.47M	515.17M	502.97M	722.17M	636.01M
Shareholder's Equity (Quarter)	98.91M	204.59M	187.72M	166.64M	141.90M	409.01M	395.06M	350.55M	315.86M	283.58M	442.02M	582.53M	529.34M	707.50M	671.64M	604.47M	515.17M	502.97M	722.17M	636.01M
Liabilities and Shareholders Equity (Quarter)	118.20M	221.21M	203.71M	183.16M	169.81M	440.58M	435.09M	386.64M	351.47M	328.76M	490.42M	630.38M	585.66M	771.90M	742.40M	660.98M	582.32M	577.14M	899.42M	789.02M
Retained Earnings (Quarter)	-315.31M	-329.40M	-358.30M	-0.94M	-413.48M	-0.94M	-0.39M	-556.33M	-0.17M	-659.05M	0.34M	-774.45M	-0.54M	-916.13M	-995.86M	0.24M	-1183.50M	0.36M	-1338.50M	-1443.36M
Preferred Shares (Quarter)		145.79M	118.16M	96.44M	15.67M	56.68M	85.47M	56.68M	56.68M	78.23M	128.28M	71.43M	128.28M	127.70M	127.70M	61.19M	61.19M	61.19M	70.87M	70.87M
Treasury Shares (Quarter)									0.25M	0.09M	0.80M	0.67M		0.51M	0.31M		1.11M	1.09M	1.06M
Shares Outstanding (Quarter)	8.61M	0.32M	23.92M	27.17M	28.46M	40.24M	41.31M	43.06M	43.56M	43.70M	53.99M	63.80M	63.88M	79.18M	80.99M	81.59M	81.65M	82.23M	101.83M	102.46M

Research Tools

Viridian Therapeutics, Inc.\DE Balance Sheet (2014-2026) | VRDN

Create an account

Sign In

Reset Password